Welcome to the ATTD 2022 Interactive Program

The conference will officially run on Central European Summer Time (UTC+2) - Barcelona Time

To convert the conference times to your local time Click Here


 

Displaying One Session

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111

Glycemic Control and Health Complications in Women Vs. Men with Type 1 and Type 2 Diabetes

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111
Lecture Time
13:00 - 13:15

Abstract

Abstract Body

While diabetes mellitus affects both men and women, there is limited data regarding gender specific differences in diabetes outcomes. Existing studies, however, reveal several differences between men and women with diabetes. As the impact of personalized medicine on improving clinical outcomes expand, gender specific health needs and treatments for people with diabetes mellitus have come to the forefront. Data regarding gender specific differences in diabetes outcomes and gender-related risk factors would be key to devise customized diabetes management plans to improve diabetes outcomes and quality of life for people with diabetes. This presentation highlights some of the health challenges that are common to women with diabetes and outlines gender-based differences, gender-specific risk enhancers and clinical outcomes in diabetes.

Hide

Psycho-Behavioral Challenges Faced by Women with Diabetes

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111
Lecture Time
13:15 - 13:30

Abstract

Abstract Body

It is well-documented that women with type 1 and type 2 diabetes report significantly higher levels of emotional distress than men with diabetes. Research has documented this for diabetes-related distress, depression, anxiety, and fear of hypoglycemia and shown that these differences occur over a broad age span, with adolescent girls reporting more distress than boys, especially problems with body image and disordered eating patterns. Increased emotional distress is also higher in mothers of children with type 1 diabetes as compared to fathers. Importantly, these gender differences appear to occur pan globally with studies emerging across continents and cultures. This presentation will review some of the psychological issues and challenges that are unique to women with diabetes. In addition, this presentation will examine some of the implications of these gender differences for the adoption and use of diabetes technology in women. To explore the impact of gender, psychological and behavioral data from recent pivotal trials of hybrid closed loop control (CLC) use will be presented, focusing primarily on Diabetes Distress Surveys completed by study participants at baseline and after 24 weeks of CLC use. These data show that more female participants, both adults and adolescents, reported clinically significant levels of diabetes distress at baseline (adult women vs. men = 38% vs 24%, adolescent girls vs. boys = 47% vs. 13%). After use of CLC, higher scores tended to remain high for the majority of participants, indicating that diabetes technology may not be effective in lowering diabetes distress.

Hide

Physiology of Menstrual Cycle and Its Relationship to Insulin Needs and Glycemic Control in Women with Type 1 Diabetes

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111
Lecture Time
13:30 - 13:45

Abstract

Abstract Body

Individuals with type 1 diabetes (T1D) need to continuously calibrate insulin therapy, to account for time-varying insulin requirements driven by multiple metabolic and psycho-behavioral factors - eg, meals, physical activity, psychological stress. Among these factors, the menstrual cycle has been documented to impact insulin needs and complicate insulin dosing in women with T1D. According to several studies, women with T1D may experience a decrease in insulin sensitivity during the second half of their menstrual cycle (ie, the luteal phase), which is oftentimes accompanied by an increased exposure to hyperglycemia. Also, increased occurrence of hypoglycemia has been documented during the initial days of the menstrual cycle, as women transition from luteal to follicular phase. These patterns are not consistent across women and elevated inter-subject variability has been observed; further, intra-subject variability has also been documented in some studies. During this talk, we will review the physiology of the menstrual cycle and the effect that phases of the menstrual cycle have on insulin requirements and glycemic control in women with T1D. Further, the talk will discuss how technology in the form of open-loop decision support systems or closed-loop automated insulin delivery systems can support women in the management of T1D across the menstrual cycle.

Hide

Automated Insulin Treatment in Women with Type 1 Diabetes: Evidence from Real-World Data

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111
Lecture Time
13:45 - 14:00

Abstract

Abstract Body

Automated Insulin Delivery systems (AID) have consistently demonstrated improved glycemic outcomes and therefore have been in increasing use for people with Type 1 Diabetes. Pivotal trials have been completed with several systems that are now available for outpatient use. Although women have been adequately represented in these pivotal trials, it is unclear if women have a different glycemic response to AID treatment. A preliminary secondary analysis of AID trials conducted at UVA identified no significant change in hemoglobin A1c or time in range following AID use comparing female and male participants. In terms of changes across the menstrual cycle, there is little information available regarding the impact of AID systems on glycemic control. Preliminary studies have not observed trends in glycemic control or insulin delivery across menstrual cycle phases during AID use, but these studies are small and uncontrolled. Available real-world data will be discussed to consider whether differences are observed between female and male users of AID systems.

Hide

Use of Technology to Improve Diabetes Management in Women with Type 2 Diabetes

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111
Lecture Time
14:00 - 14:15

Abstract

Abstract Body

There has been a steep rise in the incidence of type 2 diabetes worldwide and women are at a disproportionately higher risk of diabetes complications compared to men despite a lower disease burden. This increased risk stems from important biological and psycho-social differences between men and women as well as conditions unique to women such as pregnancy, menstruation and menopause. Understanding and addressing these differences is essential so that the quality of life and clinical outcomes of women with type 2 diabetes can be improved. Diabetes technology is transforming the landscape of type 2 diabetes management and has been shown to improve glycemic control in pregnant women with diabetes. In this session, we will discuss ideas to leverage diabetes technology to improve diabetes management specially in women with type 2 diabetes.

Hide

Q&A

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
13:00 - 14:30
Room
Hall 111
Lecture Time
14:15 - 14:30